.png)
AI's significance in genomics lies in its ability to uncover hidden patterns, provide diagnostic insights, and enhance our understanding of genetic information. The reason AI can be so helpful in genetics is that the complexity and sheer volume of genomic data poses significant challenges to traditional methods, which struggle to efficiently analyse and interpret this information. AI addresses this hurdle by offering computational tools capable of handling, extracting, and deciphering valuable insights from a huge amount of data.
Integrating precision medicine into clinical practice offers immense benefits for patient care but also poses significant challenges and ethical considerations that need careful navigation in the coming years. Here's a summary of the key issues:
In the latest episode of The Genetics Podcast, Sano CEO Patrick Short had a fascinating discussion with Dr. Andrea Gropman, a distinguished expert in paediatric neurology, genetics, and inborn errors of metabolism. Dr. Gropman shared her extensive experience in the field and discussed the challenges and opportunities in integrating genetics and genomics into modern medical practice.
Last week on The Genetics Podcast, Sano CEO Patrick Short sat down with Lori Orlando, Director of the Precision Medicine Program at the Center for Applied Genomics and Precision Medicine at Duke University. Lori shared her journey from mathematical modelling to integrating family history and genetic data into primary care, discussing the impact of genomics on healthcare and the future of personalised medicine.
The incorporation of genetics into contemporary clinical practice is essential for facilitating personalised treatment plans and early diagnosis, and can lead to significantly better patient outcomes. This guide provides healthcare providers with a comprehensive overview of how to effectively integrate genetic data into clinical settings. Here are some key points covered:
In terms of identifying and supporting at-risk populations, genomics has multiple potential applications in frontline healthcare. While confirmation of an underlying genetic factor can’t currently change patient outcomes, it’s hoped that collecting genomic data will enable families to quickly identify members at increased risk, and ultimately accelerate the development of potential new drug targets and personalised treatment journeys.
The advancement of precision medicine hinges on supportive policies, legislative frameworks, and collaborative efforts that foster innovation, streamline regulatory processes, and ensure equitable access to cutting-edge treatments. Here, we share notable policy initiatives and examples of collaborative efforts in the United States and the United Kingdom, highlighting their goals, implementation, and potential impacts.
In the latest episode of The Genetics Podcast, Sano CEO Patrick Short had an enlightening conversation with Ben Goldacre, a prominent figure in healthcare data and open science. Ben discussed his pivotal work at the Bennett Institute, highlighting projects that leverage open data to improve healthcare outcomes.
British toddler Opal Sandy has had her hearing restored thanks to a first-of-its-kind gene therapy. Eighteen-month-old Opal received the treatment as part of the CHORD study (sponsored by biotechnology company, Regeneron), which offers the therapy – DB-OTO – to children born with OTOF linked hearing loss. The Guardian reported last month that Opal’s parents “couldn’t really believe it,” when their daughter was able to hear for the first time after receiving the treatment.
Establishing robust policy frameworks to support precision medicine involves creating an ecosystem that fosters innovation, ensures safety and efficacy, and promotes equitable access. This includes addressing challenges and opportunities related to privacy, data protection, insurance, and genetic discrimination. Here, we outline the key strategies and components for setting up such programs, focusing on regulatory frameworks, data infrastructure, funding, ethical considerations, and collaborative ecosystems.